SCHEMBL5006828

SCHEMBL5006828

CCC(CCc1ccccc1)(CC(=O)c1ccc(-c2ccc(N)cc2)cc1C)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 1/20 0.41
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
SLC13A5 Q86YT5 5/20 0.37
MCL1 Q07820 1/20 0.36
OXTR P30559 1/20 0.36
AVPR1A P37288 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
MRGPRX4 Q96LA9 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HIF1A Q16665 1/20 0.34
HCAR2 Q8TDS4 1/20 0.34
GRIN2B Q13224 1/20 0.34
BCL2 P10415 1/20 0.33
GRM2 Q14416 1/20 0.33
GRM3 Q14832 1/20 0.33
PPARG P37231 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5007313 0.87 SMN1; SMN2 (0.42) RARBSLC13A5NPC1RAB9ASMN1; SMN2
SCHEMBL5006829 0.86 NPC1 (0.42) RARBNPC1RAB9ASMN1; SMN2
SCHEMBL5005989 0.73 SMN1; SMN2 (0.42) RARBPDE4DNPC1RAB9ASMN1; SMN2
SCHEMBL2395007 0.72 MAPT (0.48) NPC1RAB9ASMN1; SMN2
SCHEMBL1748179 0.72 NPC1 (0.43) RARBPDE4APDE4BPDE4CPDE4D
SCHEMBL585945 0.71 ALDH1A1 (0.47) SLC13A5NPC1RAB9ASMN1; SMN2HIF1A
SCHEMBL18085386 0.71 ALDH1A1 (0.47) SLC13A5NPC1RAB9ASMN1; SMN2HIF1A
SCHEMBL5006802 0.71 HDAC3 (0.44) NPC1RAB9A
SCHEMBL12313907 0.71 RARB (0.40) RARBPDE4APDE4BPDE4CPDE4D
SCHEMBL12428576 0.69 AR (0.44) RARBNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423156-B2 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity BAYER PHARMACEUTICALS CORPORATION (US) 2008-09-09 US disclosed